Evaluation of Microbial Risk Factors in Relation to Clinical Effectiveness of Off-Label Bevacizumab Use for Retinal Disease Treatment: Research Article. Pak-Euro Journal of Medical and Life Sciences, v. 9, n. 1, p. 25–34, 31 Mar.2026.